Overview
This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.
Eligibility
Inclusion Criteria:
- Age 18+
- Urinary cannabinoid level ≥ 50 ng/mL
- DSM-5 diagnosis of CUD (mild, moderate, or severe)
- Willingness to attempt cannabis reduction
- Completion of Intake Visit
Exclusion Criteria:
- Serious medical/psychiatric conditions
- Pregnancy or breastfeeding
- Use of cannabis in past 30 days was for medical purposes only
- Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition
- Cognitive or understanding difficulties, as evidenced by inability to pass informed consent quiz


